Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

John Murphy

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Living Beings

Genes & Molecular Sequences

Amino Acid Sequence

Anatomy

Physiology

Site-Directed Mutagenesis

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
27
Strom, Terry
24
vanderSpek, Johanna
6
Zeng, Huiyan
6
Ringe, Dagmar
6
Bishai, William
5
Love, John
4
Logan, Timothy
3
Ratts, Ryan
3
Marin, Vedrana
3
Foss, Francine
2
Bharti, Ajit
2
Bienkiewicz, Ewa
2
Gaillard, C
2
Gillet, Daniel
2
Guerrero, Luis

Sign-in to see all Coauthors

Publications

TOP 3
Wright Daniel G; Zhang Ying; Murphy John R
Effective delivery of antisense peptide nucleic acid oligomers into cells by anthrax protective antigen.
Chiavolini Damiana; Weir Susan; Murphy John R; Wetzler Lee M
Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia.
Tamayo Alfred G; Bharti Ajit; Trujillo Carolina; Harrison Robert; Murphy John R
COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Murphy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Wright Daniel G; Zhang Ying; Murphy John R
Effective delivery of antisense peptide nucleic acid oligomers into cells by anthrax protective antigen.
Biochemical and biophysical research communications 2008;376(1):200-5.
2008: Chiavolini Damiana; Weir Susan; Murphy John R; Wetzler Lee M
Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia.
Clinical and vaccine immunology : CVI 2008;15(9):1322-9.
2008: Tamayo Alfred G; Bharti Ajit; Trujillo Carolina; Harrison Robert; Murphy John R
COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(13):5254-9.
2008: Chiavolini Damiana; Alroy Joseph; King Carol A; Jorth Peter; Weir Susan; Madico Guillermo; Murphy John R; Wetzler Lee M
Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.
Infection and immunity 2008;76(2):486-96.
2006: Trujillo C; Ratts R; Tamayo A; Harrison R; Murphy J R
Trojan horse or proton force: finding the right partner(s) for toxin translocation.
Neurotoxicity research 2006;9(2-3):63-71.
2005: Ratts Ryan; Trujillo Carolina; Bharti Ajit; vanderSpek Johanna; Harrison Robert; Murphy John R
A conserved motif in transmembrane helix 1 of diphtheria toxin mediates catalytic domain delivery to the cytosol.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(43):15635-40.
2005: Rangachari Vijayaraghavan; Marin Vedrana; Bienkiewicz Ewa A; Semavina Maria; Guerrero Luis; Love John F; Murphy John R; Logan Timothy M
Sequence of ligand binding and structure change in the diphtheria toxin repressor upon activation by divalent transition metals.
Biochemistry 2005;44(15):5672-82.
2005: Wylie Gregory P; Rangachari Vijayaraghavan; Bienkiewicz Ewa A; Marin Vedrana; Bhattacharya Nilakshee; Love John F; Murphy John R; Logan Timothy M
Prolylpeptide binding by the prokaryotic SH3-like domain of the diphtheria toxin repressor: a regulatory switch.
Biochemistry 2005;44(1):40-51.
2004: Love John F; vanderSpek Johanna C; Marin Vedrana; Guerrero Luis; Logan Timothy M; Murphy John R
Genetic and biophysical studies of diphtheria toxin repressor (DtxR) and the hyperactive mutant DtxR(E175K) support a multistep model of activation.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(8):2506-11.
2003: Love John F; VanderSpek Johanna C; Murphy John R
The src homology 3-like domain of the diphtheria toxin repressor (DtxR) modulates repressor activation through interaction with the ancillary metal ion-binding site.
Journal of bacteriology 2003;185(7):2251-8.
2003: Ratts Ryan; Zeng Huiyan; Berg Eric A; Blue Clare; McComb Mark E; Costello Cathy E; vanderSpek Johanna C; Murphy John R
The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex.
The Journal of cell biology 2003;160(7):1139-50.
2002: Love John F; Murphy John R
Design and development of a novel genetic probe for the analysis of repressor-operator interactions.
Journal of microbiological methods 2002;51(1):63-72.
2002: vanderSpek Johanna C; Sutherland John A; Gill Brian M; Gorgun Gullu; Foss Francine M; Murphy John R
Structure function analysis of interleukin 7: requirement for an aromatic ring at position 143 of helix D.
Cytokine 2002;17(5):227-33.
2000: Chen C S; White A; Love J; Murphy J R; Ringe D
Methyl groups of thymine bases are important for nucleic acid recognition by DtxR.
Biochemistry 2000;39(34):10397-407.
2000: Francis J W; Brown R H; Figueiredo D; Remington M P; Castillo O; Schwarzschild M A; Fishman P S; Murphy J R; vanderSpek J C
Enhancement of diphtheria toxin potency by replacement of the receptor binding domain with tetanus toxin C-fragment: a potential vector for delivering heterologous proteins to neurons.
Journal of neurochemistry 2000;74(6):2528-36.
2000: Cosenza L; Rosenbach A; White J V; Murphy J R; Smith T
Comparative model building of interleukin-7 using interleukin-4 as a template: a structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation.
Protein science : a publication of the Protein Society 2000;9(5):916-26.
2000: vanderSpek J C; Murphy J R
Fusion protein toxins based on diphtheria toxin: selective targeting of growth factor receptors of eukaryotic cells.
Methods in enzymology 2000;327():239-49.
2000: vanderSpek J C; Murphy J R
Genetic construction, expression, and characterization of diphtheria toxin-based growth factor fusion proteins.
Methods in molecular biology (Clifton, N.J.) 2000;145():89-99.
1999: Wang G; Wylie G P; Twigg P D; Caspar D L; Murphy J R; Logan T M
Solution structure and peptide binding studies of the C-terminal src homology 3-like domain of the diphtheria toxin repressor protein.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(11):6119-24.
1998: Sun L; vanderSpek J; Murphy J R
Isolation and characterization of iron-independent positive dominant mutants of the diphtheria toxin repressor DtxR.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(25):14985-90.
1998: Liger D; Nizard P; Gaillard C; vanderSpek J C; Murphy J R; Pitard B; Gillet D
The diphtheria toxin transmembrane domain as a pH sensitive membrane anchor for human interleukin-2 and murine interleukin-3.
Protein engineering 1998;11(11):1111-20.
1998: Hu H Y; Huynh P D; Murphy J R; vanderSpek J C
The effects of helix breaking mutations in the diphtheria toxin transmembrane domain helix layers of the fusion toxin DAB389IL-2.
Protein engineering 1998;11(9):811-7.
1998: White A; Ding X; vanderSpek J C; Murphy J R; Ringe D
Structure of the metal-ion-activated diphtheria toxin repressor/tox operator complex.
Nature 1998;394(6692):502-6.
1998: Sweeney E B; Foss F M; Murphy J R; vanderSpek J C
Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cells.
Bioconjugate chemistry 1998;9(2):201-7.
1998: Foss F M; Saleh M N; Krueger J G; Nichols J C; Murphy J R
Diphtheria toxin fusion proteins.
Current topics in microbiology and immunology 1998;234():63-81.
1997: Cosenza L; Sweeney E; Murphy J R
Disulfide bond assignment in human interleukin-7 by matrix-assisted laser desorption/ionization mass spectroscopy and site-directed cysteine to serine mutational analysis.
The Journal of biological chemistry 1997;272(52):32995-3000.
1997: Liger D; vanderSpek J C; Gaillard C; Cansier C; Murphy J R; Leboulch P; Gillet D
Characterization and receptor specific toxicity of two diphtheria toxin-related interleukin-3 fusion proteins DAB389-mIL-3 and DAB389-(Gly4Ser)2-mIL-3.
FEBS letters 1997;406(1-2):157-61.
1997: Lemichez E; Bomsel M; Devilliers G; vanderSpek J; Murphy J R; Lukianov E V; Olsnes S; Boquet P
Membrane translocation of diphtheria toxin fragment A exploits early to late endosome trafficking machinery.
Molecular microbiology 1997;23(3):445-57.
1997: vanderSpek J C; Sutherland J A; Zeng H; Battey J F; Jensen R T; Murphy J R
Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
Cancer research 1997;57(2):290-4.
1996: Fisher C E; Sutherland J A; Krause J E; Murphy J R; Leeman S E; vanderSpek J C
Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro destruction of cells bearing substance P receptors.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(14):7341-5.
1996: vanderSpek J C; Sutherland J A; Ratnarathorn M; Howland K; Ciardelli T L; Murphy J R
DAB389 interleukin-2 receptor binding domain mutations. Cytotoxic probes for studies of ligand-receptor interactions.
The Journal of biological chemistry 1996;271(21):12145-9.
1996: Ding X; Zeng H; Schiering N; Ringe D; Murphy J R
Identification of the primary metal ion-activation sites of the diphtheria tox repressor by X-ray crystallography and site-directed mutational analysis.
Nature structural biology 1996;3(4):382-7.
1995: vanderSpek J C; Sutherland J; Sampson E; Murphy J R
Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389 sIL-15.
Protein engineering 1995;8(12):1317-21.
1995: Murphy J R; vanderSpek J C
Targeting diphtheria toxin to growth factor receptors.
Seminars in cancer biology 1995;6(5):259-67.
1995: Schiering N; Tao X; Zeng H; Murphy J R; Petsko G A; Ringe D
Structures of the apo- and the metal ion-activated forms of the diphtheria tox repressor from Corynebacterium diphtheriae.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(21):9843-50.
1995: Tao X; Zeng H Y; Murphy J R
Transition metal ion activation of DNA binding by the diphtheria tox repressor requires the formation of stable homodimers.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(15):6803-7.
1995: Sweeney E B; Murphy J R
Diphtheria toxin-based receptor-specific chimaeric toxins as targeted therapies.
Essays in biochemistry 1995;30():119-31.
1994: Schiering N; Tao X; Murphy J R; Petsko G A; Ringe D
Crystallization and preliminary X-ray studies of the diphtheria Tox repressor from Corynebacterium diphtheriae.
Journal of molecular biology 1994;244(5):654-6.
1994: Tao X; Schiering N; Zeng H Y; Ringe D; Murphy J R
Iron, DtxR, and the regulation of diphtheria toxin expression.
Molecular microbiology 1994;14(2):191-7.
1994: Tao X; Murphy J R
Determination of the minimal essential nucleotide sequence for diphtheria tox repressor binding by in vitro affinity selection.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(20):9646-50.
1994: vanderSpek J; Cosenza L; Woodworth T; Nichols J C; Murphy J R
Diphtheria toxin-related cytokine fusion proteins: elongation factor 2 as a target for the treatment of neoplastic disease.
Molecular and cellular biochemistry 1994;138(1-2):151-6.
1994: vanderSpek J; Cassidy D; Genbauffe F; Huynh P D; Murphy J R
An intact transmembrane helix 9 is essential for the efficient delivery of the diphtheria toxin catalytic domain to the cytosol of target cells.
The Journal of biological chemistry 1994;269(34):21455-9.
1994: vanderSpek J C; Howland K; Friedman T; Murphy J R
Maintenance of the hydrophobic face of the diphtheria toxin amphipathic transmembrane helix 1 is essential for the efficient delivery of the catalytic domain to the cytosol of target cells.
Protein engineering 1994;7(8):985-9.
1994: van der Spek J; Hémard A; Dautry-Varsat A; Boquet P; Murphy J R
Epitope tagging of DAB389IL-2: new insights into C-domain delivery to the cytosol of target cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8 Suppl 1():S144-8.
1994: Strom T B; Kelley V R; Murphy J R; Nichols J; Woodworth T G
Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
Advances in nephrology from the Necker Hospital 1994;23():347-56.
1993: Tao X; Murphy J R
Cysteine-102 is positioned in the metal binding activation site of the Corynebacterium diphtheriae regulatory element DtxR.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8524-8.
1993: vanderSpek J C; Mindell J A; Finkelstein A; Murphy J R
Structure/function analysis of the transmembrane domain of DAB389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells.
The Journal of biological chemistry 1993;268(16):12077-82.
1993: Jean L F; Waters C A; Keemy D; Murphy J R
Site-directed and deletion mutational analysis of the receptor binding domain of the interleukin-6 receptor targeted fusion toxin DAB389-IL-6.
Protein engineering 1993;6(3):305-11.
1993: Strom T B; Kelley V R; Murphy J R; Nichols J; Woodworth T G
Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting molecules.
Annual review of medicine 1993;44():343-53.
1992: Strom T B; Kelley V R; Woodworth T G; Murphy J R
Interleukin-2 receptor-directed immunosuppressive therapies: antibody- or cytokine-based targeting molecules.
Immunological reviews 1992;129():131-63.
1992: Tao X; Murphy J R
Binding of the metalloregulatory protein DtxR to the diphtheria tox operator requires a divalent heavy metal ion and protects the palindromic sequence from DNase I digestion.
The Journal of biological chemistry 1992;267(30):21761-4.
1992: Tao X; Boyd J; Murphy J R
Specific binding of the diphtheria tox regulatory element DtxR to the tox operator requires divalent heavy metal ions and a 9-base-pair interrupted palindromic sequence.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(13):5897-901.
1992: Lakkis F; Landgraf B; Wen Z; Strom T B; Murphy J R
Phe496 and Leu497 are essential for receptor binding and cytotoxic action of the murine interleukin-4 receptor targeted fusion toxin DAB389-mIL-4.
Protein engineering 1992;5(3):241-8.
1992: Pacheco-Silva A; Bastos M G; Muggia R A; Pankewycz O; Nichols J; Murphy J R; Strom T B; Rubin-Kelley V E
Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
European journal of immunology 1992;22(3):697-702.
1992: Boyd J M; Hall K C; Murphy J R
DNA sequences and characterization of dtxR alleles from Corynebacterium diphtheriae PW8(-), 1030(-), and C7hm723(-).
Journal of bacteriology 1992;174(4):1268-72.
1991: Jean L F; Murphy J R
Diphtheria toxin receptor-binding domain substitution with interleukin 6: genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein.
Protein engineering 1991;4(8):989-94.
1991: Waters C A; Snider C E; Itoh K; Poisson L; Strom T B; Murphy J R; Nichols J C
DAB486IL-2 (IL-2 toxin) selectively inactivates high-affinity IL-2 receptor-bearing human peripheral blood mononuclear cells.
Annals of the New York Academy of Sciences 1991;636():403-5.
1991: Kiyokawa T; Williams D P; Snider C E; Waters C A; Nichols J C; Strom T B; Murphy J R
Protein engineering of DAB-IL-2 fusion toxins to increase biologic potency.
Annals of the New York Academy of Sciences 1991;636():331-9.
1991: Strom T B; Anderson P L; Rubin-Kelley V E; Williams D P; Kiyokawa T; Murphy J R
Immunotoxins and cytokine toxin fusion proteins.
Annals of the New York Academy of Sciences 1991;636():233-50.
1991: Yamaguchi K; Futami G; Kiyokawa T; Ishii T; Murphy J R; Takatsuki K
Adult T cell leukemia/lymphoma. Perspectives on the treatment.
Annals of the New York Academy of Sciences 1991;636():165-70.
1991: Lakkis F; Steele A; Pacheco-Silva A; Rubin-Kelley V; Strom T B; Murphy J R
Interleukin 4 receptor targeted cytotoxicity: genetic construction and in vivo immunosuppressive activity of a diphtheria toxin-related murine interleukin 4 fusion protein.
European journal of immunology 1991;21(9):2253-8.
1991: Wen Z L; Tao X; Lakkis F; Kiyokawa T; Murphy J R
Diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion toxin. Internal in-frame deletion from Thr387 to His485 results in the formation of a highly potent fusion toxin which is resistant to proteolytic degradation.
The Journal of biological chemistry 1991;266(19):12289-93.
1991: Kiyokawa T; Williams D P; Snider C E; Strom T B; Murphy J R
Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells.
Protein engineering 1991;4(4):463-8.
1990: Bastos M G; Pankewycz O; Rubin-Kelley V E; Murphy J R; Strom T B
Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(11):3535-9.
1990: Williams D P; Wen Z; Watson R S; Boyd J; Strom T B; Murphy J R
Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194.
The Journal of biological chemistry 1990;265(33):20673-7.
1990: Strom T B; Anderson P L; Rubin-Kelley V E; Williams D P; Kiyokawa T; Murphy J R
Immunotoxins and cytokine toxin fusion proteins.
Seminars in immunology 1990;2(6):467-79.
1990: Boyd J; Oza M N; Murphy J R
Molecular cloning and DNA sequence analysis of a diphtheria tox iron-dependent regulatory element (dtxR) from Corynebacterium diphtheriae.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5968-72.
1990: Williams D P; Snider C E; Strom T B; Murphy J R
Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells.
The Journal of biological chemistry 1990;265(20):11885-9.
1990: Waters C A; Schimke P A; Snider C E; Itoh K; Smith K A; Nichols J C; Strom T B; Murphy J R
Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells.
European journal of immunology 1990;20(4):785-91.
1990: Walz G; Zanker B; Murphy J R; Strom T B
A kinetic analysis of the effects of interleukin-2 diphtheria toxin fusion protein upon activated T cells.
Transplantation 1990;49(1):198-201.
1989: Walz G; Zanker B; Brand K; Waters C; Genbauffe F; Zeldis J B; Murphy J R; Strom T B
Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(23):9485-8.
1989: Kiyokawa T; Shirono K; Hattori T; Nishimura H; Yamaguchi K; Nichols J C; Strom T B; Murphy J R; Takatsuki K
Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia.
Cancer research 1989;49(14):4042-6.
1989: Barrett L V; Murphy J R; Strom T B; Kirkman R L
Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in mice.
Transplantation proceedings 1989;21(1 Pt 1):1130-1.
1989: Kirkman R L; Bacha P; Barrett L V; Forte S; Murphy J R; Strom T B
Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin-2 fusion protein.
Transplantation 1989;47(2):327-30.
1989: Mackie J D; Pankewycz O G; Hassarjian R; Murphy J R; Kelley V E; Strom T B
Immunotherapy using interleukin-2 diphtheria toxin chimer prolongs murine allografts.
Transplantation proceedings 1989;21(1 Pt 3):2718-9.
1989: Pankewycz O; Mackie J; Hassarjian R; Murphy J R; Strom T B; Kelley V E
Interleukin-2-diphtheria toxin fusion protein prolongs murine islet cell engraftment.
Transplantation 1989;47(2):318-22.
1988: Boyd J; Murphy J R
Analysis of the diphtheria tox promoter by site-directed mutagenesis.
Journal of bacteriology 1988;170(12):5949-52.
1988: Williams D P; Regier D; Akiyoshi D; Genbauffe F; Murphy J R
Design, synthesis and expression of a human interleukin-2 gene incorporating the codon usage bias found in highly expressed Escherichia coli genes.
Nucleic acids research 1988;16(22):10453-67.
1988: Kelley V E; Bacha P; Pankewycz O; Nichols J C; Murphy J R; Strom T B
Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(11):3980-4.
1988: Bacha P; Williams D P; Waters C; Williams J M; Murphy J R; Strom T B
Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
The Journal of experimental medicine 1988;167(2):612-22.
1988: Murphy J R; Kelley V E; Strom T B
Interleukin 2 toxin: a step toward selective immunomodulation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):159-62.
1988: Murphy J R; Williams D P; Bacha P; Bishai W; Waters C; Strom T B
Cell receptor specific targeted toxins: genetic construction and characterization of an interleukin 2 diphtheria toxin-related fusion protein.
Journal of receptor research 1988;8(1-4):467-80.
1987: Williams D P; Parker K; Bacha P; Bishai W; Borowski M; Genbauffe F; Strom T B; Murphy J R
Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein.
Protein engineering 1987;1(6):493-8.
1987: Bishai W R; Rappuoli R; Murphy J R
High-level expression of a proteolytically sensitive diphtheria toxin fragment in Escherichia coli.
Journal of bacteriology 1987;169(11):5140-51.
1987: Bishai W R; Miyanohara A; Murphy J R
Cloning and expression in Escherichia coli of three fragments of diphtheria toxin truncated within fragment B.
Journal of bacteriology 1987;169(4):1554-63.
1987: Murphy J R; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom T B
Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
Biochemical Society symposium 1987;53():9-23.
1986: Murphy J R; Bishai W; Borowski M; Miyanohara A; Boyd J; Nagle S
Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(21):8258-62.

Sign-in to see more